Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering (11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione.

Client Email

Product

(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

Coral Budesonide

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

65 API Suppliers, 24 USDMF, 25 CEP/COS, 7 JDMF, 7 EU WC, 15 KDMF, 34 NDC API, 43 Listed Suppliers, $ API Reference Price

65 API Suppliers
24 USDMF
25 CEP/COS
7 JDMF
7 EU WC
15 KDMF
34 NDC API
43 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

71 Drugs in Development

71 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

6 API Suppliers

6 API Suppliers

FINISHED DOSAGE FORMULATIONS

611 FDF Dossiers, 54 FDA Orange Book, 429 Europe, 23 Canada, 13 Australia, 39 South Africa, 53 Listed Dossiers

611 FDF Dossiers
54 FDA Orange Book
429 Europe
23 Canada
13 Australia
39 South Africa
53 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG, AEROSOL, FOAM;RECTAL - 2MG/ACTUATION, SPRAY, METERED;NASAL - 0.032MG/SPRAY, SUSPENSION;INHALATION - 0.25MG/2ML, SUSPENSION;INHALATION - 0.5MG/2ML, SUSPENSION;INHALATION - 1MG/2ML, CAPSULE, DELAYED RELEASE;ORAL - 6MG, CAPSULE, DELAYED RELEASE;ORAL - 9MG, CAPSULE, DELAYED RELEASE;ORAL - 3MG, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

TABLET, EXTENDED RELEASE;ORAL - 9MG
AEROSOL, FOAM;RECTAL - 2MG/ACTUATION
SPRAY, METERED;NASAL - 0.032MG/SPRAY
SUSPENSION;INHALATION - 0.25MG/2ML
SUSPENSION;INHALATION - 0.5MG/2ML
SUSPENSION;INHALATION - 1MG/2ML
CAPSULE, DELAYED RELEASE;ORAL - 6MG
CAPSULE, DELAYED RELEASE;ORAL - 9MG
CAPSULE, DELAYED RELEASE;ORAL - 3MG
AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH
AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 2 Seqens, 9 DKSH, 1 Jai Radhe Sales, 10 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 1 Clariant, 14 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 10 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 31 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

67 Coating Systems & Additives, 66 Fillers, Diluents & Binders, 41 Controlled & Modified Release, 33 Thickeners and Stabilizers, 30 Direct Compression, 24 Solubilizers, 20 Film Formers & Plasticizers, 20 Granulation, 19 Taste Masking, 19 Lubricants & Glidants, 18 Topical, 16 Parenteral, 15 Co-Processed Excipients, 11 Disintegrants & Superdisintegrants, 9 Empty Capsules, 9 Emulsifying Agents, 6 Rheology Modifiers, 6 Chewable & Orodispersible Aids, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

67 Coating Systems & Additives
66 Fillers, Diluents & Binders
41 Controlled & Modified Release
33 Thickeners and Stabilizers
30 Direct Compression
24 Solubilizers
20 Film Formers & Plasticizers
20 Granulation
19 Taste Masking
19 Lubricants & Glidants
18 Topical
16 Parenteral
15 Co-Processed Excipients
11 Disintegrants & Superdisintegrants
9 Empty Capsules
9 Emulsifying Agents
6 Rheology Modifiers
6 Chewable & Orodispersible Aids
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 129 NEWS #PharmaBuzz

5 DATA COMPILATION #PharmaFlow
1 STOCK RECAP #PipelineProspector
129 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 232 Finished Drug Prices, 37 Annual Reports

5 US Medicaid Prescriptions
232 Finished Drug Prices
37 Annual Reports

MARKET PLACE

17 APIs, 17 FDF Dossiers, 1 EXCIPIENTS

17 APIs
17 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

53 US Patents, 5 US Exclusivities, 2 Health Canada Patents

53 US Patents
5 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 13 Others

2 EDQM
4 USP
13 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 3,439 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 1AstraZeneca Canada Inc.

02 1Ferring Inc.

filter Patent Reset all filters

2 All

01 12071518

02 12377301

filter Product Reset all filters

2 All

01 1BUDESONIDE

02 1Budesonide

filter Dosage Reset all filters

2 All

01 1Capsule

02 1TABLET (DELAYED AND EXTENDED RELEASE)

filter Exp Date Reset all filters

2 All

01 12010-11-15

02 12020-06-09

Minakem Budesonide

US Patents
US Exclusivities
Health Canada Patents

Product Main Page

01

AstraZeneca Canada Inc.

Budesonide

AAPS 2024

Not Confirmed

AstraZeneca Canada Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-11-15

Date Granted : 2002-11-12

Brand Name : ENTOCORT

Patent Number : 2071518

Filing Date : 1990-11-15

Strength per Unit : 3 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-11-15

Date Granted : 2002-11-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Ferring Inc.

Budesonide

AAPS 2024

Not Confirmed

Ferring Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-06-09

Date Granted : 2009-05-12

Brand Name : CORTIMENT

Patent Number : 2377301

Filing Date : 2000-06-09

Strength per Unit : 9 mg

Dosage Form : TABLET (DELAYED AND EXTENDED RELEASE)

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2020-06-09

Date Granted : 2009-05-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?